JB Chemicals surges on acquiring portfolio of brands from Dr Reddy`s
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
https://t.me/InvestmentGuruIndiacom
Download Telegram App before Joining the Channel
JB Chemicals & Pharmaceuticals is currently trading at Rs. 1691.90, up by 12.15 points or 0.72% from its previous closing of Rs. 1679.75 on the BSE.
The scrip opened at Rs. 1685.05 and has touched a high and low of Rs. 1699.00 and Rs. 1659.25 respectively. So far 1547 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1984.75 on 28-Sep-2021 and a 52 week low of Rs. 1339.05 on 16-Jun-2022.
Last one week high and low of the scrip stood at Rs. 1699.00 and Rs. 1627.70 respectively. The current market cap of the company is Rs. 13006.96 crore.
The promoters holding in the company stood at 54.00%, while Institutions and Non-Institutions held 26.65% and 19.35% respectively.
JB Chemicals & Pharmaceuticals has completed the acquisition of portfolio of brands from Dr Reddy’s Laboratories. This acquisition was partly funded from internal accruals and partly through long-term debt. Earlier, the company’s board had approved a proposal to acquire four paediatric brands from Dr Reddy's Laboratories for about Rs 98 crore.
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
